Approved Drugs for Ophthalmology

Drugs Approved in 2008

Drugs Approved in 2007

• AzaSite (azithromycin); For the treatment of bacterial conjunctivitis; InSite Vision; Approved April 2007

Drugs Approved in 2006

• Lucentis (ranibizumab); For the treatment of neovascular (wet) age related macular degeneration; Genentech; Approved June 2006

Drugs Approved in 2005

Drugs Approved in 2004

• Macugen (pegaptanib); For the treatment of wet age-related macular degeneration.; Pfizer / Eyetech Pharmaceuticals; Approved December 2004

Drugs Approved in 2003

Drugs Approved in 2002

• Restasis (cyclosporine ophthalmic emulsion); For the treatment of low tear production.; Allergan; December 2002

Drugs Approved in 2001

• Lumigan (bimatoprost ophthalmic solution); For the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension; Allergan; Approved March 2001
• Travatan (travoprost ophthalmic solution); For the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension; Alcon Laboratories; Approved March 2001
• Valcyte (valganciclovir HCl); For the treatment of cytomegalovirus retinitis in patients with AIDS; Roche; Approved March 2001

Drugs Approved in 2000

• Betaxon; For lowering IOP in patients with chronic open-angle glaucoma or ocular hypertension; Alcon Laboratories; Approved February 2000
• Quixin (levofloxacin); For treatment of bacterial conjunctivitis; Santen; Approved August 2000
• Rescula (unoprostone isopropyl ophthalmic solution) 0.15%; For the treatment of open-angle glaucoma or ocular hypertension; Ciba Vision; Approved August 2000
• Visudyne (verteporfin for injection); For the treatment of wet age-related macular degeneration (wet AMD); QLT; Approved April 2000

Drugs Approved in 1999

• Alamast; pemirolast potassium ophthalmic solution; Santen; Approved September 1999
• ZADITOR; Treatment for the prevention of itching of the eye; Ciba Vision; Approved July 1999

Drugs Approved in 1998

• Alrex; Treatment for seasonal allergic conjunctivitis; Bausch & Lomb, Pharmos; Approved March 1998
• Cosopt; Treatment for glaucoma or ocular hypertension; Merck; Approved April 1998
• Lotemax; Treatment for post-operative eye inflammation; Bausch & Lomb, Pharmos; Approved March 1998
• Salagen Tablets; Treatment for Sjogren's Syndrome; MGI Pharma; Approved February 1998
• Viroptic; Treatment for inflammation of the cornea in children due to herpes simplex virus; King Pharmaceuticals; Approved February 1998
• Vitravene Injection; Treatment for CMV in AIDS patients; Isis Pharmaceuticals; Approved August 1998

Drugs Approved in 1997

• Acular; Treatment for post-surgical inflammation following cataract extraction; Allergan; Approved November 1997
• Acular (ketorolac tromethamine ophthalmic solution) 0.5%; Treatment for postoperative inflammation in patients who have undergone cataract extraction; Allergan; Approved January 1997
• BSS Sterile Irrigating Solution; Treatment during ocular surgical procedures; Alcon Laboratories; Approved December 1997

Drugs Approved in 1996

• AK-Con-A (naphazoline ophthalmic); Over-the-counter combination vasoconstrictor/antihistamine product for opthalmic use; Akorn; Approved January 1996
• Alphagan (brimonidine); Treatment for open-angle glaucoma and ocular hypertension; Allergan; Approved September 1996
• Ocuflox (ofloxacin opthalmic solution) 0.3%; Treatment for corneal ulcers; Allergan; Approved May 1996
• OcuHist; Over-the-counter antihistamine eye drop; Pfizer; Approved January 1996
• Vistide (cidofovir injection); Treatment for cytomegalovirus (CMV) retinitis; Gilead Sciences; Approved June 1996
• Vitrasert Implant; Drug delivery system for the treatment of cytomegalovirus; Chiron Vision; Approved March 1996

Drugs Approved in 1995